West-Ward Recalls Glycopyrrolate Tablets Due to Subpotency
West-Ward recalls 1,185 bottles of 1 mg Glycopyrrolate tablets (Lot 69001A) due to subpotent drug issues. Check your medication immediately.
Use caution until it’s fixed
Subpotent Drug
Contact the company
What happened, in plain English
West-Ward Pharmaceutical Corp. is recalling one lot of Glycopyrrolate Tablets, USP, 1 mg because the drug is subpotent. The affected product consists of 1,185 bottles distributed in Ohio. A subpotent drug may not provide the intended therapeutic effect. Read more at govinfonow.com/recall/48421-west-ward-pharmaceutical-corp-recalls-glycopyrrolate-tablets-usp-1-mg.
Source Summary by GovInfoNow · govinfonow.com/recall/48421-west-ward-pharmaceutical-corp-recalls-glycopyrrolate-tablets-usp-1-mg · Updated October 13, 2026 · FDA enforcement record: FDA #D-164-2013
Cite this page
“West-Ward Recalls Glycopyrrolate Tablets Due to Subpotency.” GovInfoNow, updated October 13, 2026. https://govinfonow.com/recall/48421-west-ward-pharmaceutical-corp-recalls-glycopyrrolate-tablets-usp-1-mg. Based on FDA recall #D-164-2013 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-164-2013%22&limit=1).
Why it’s dangerous
The tablets are classified as subpotent, meaning they contain less of the active ingredient than labeled. This can result in the medication failing to treat the condition it was prescribed for effectively.
Who’s affected
Patients in Ohio who have been prescribed or possess Glycopyrrolate Tablets, USP, 1 mg from the specific lot identified in this recall are affected. These individuals rely on the medication for its intended medical use.
How to tell if you have this one
Check your bottle for the National Drug Code (NDC) 0143-1250-01 and Lot Number 69001A. The product is manufactured by West-Ward Pharmaceutical Corp. in Eatontown, NJ, and contains 100 tablets per bottle.
- Brand
West-Ward Pharmaceutical- Category
Drug
What to do — step by step
Contact Your Pharmacist
Reach out to your pharmacy or healthcare provider to discuss the recall and determine if you have the affected lot.
Verify Lot Number
Inspect your medication bottle for NDC 0143-1250-01 and Lot #69001A to confirm if it is part of this recall.
Where it went and when
Where it was distributed
Distributed in Ohio.
FDA distribution: “OH” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: Ohio.
Recall timeline
FDA terminated this recall 16 months after the firm started it.
- Firm started the recall
- FDA classified it Class III
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-164-2013 (January 7, 2013) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-164-2013 to see it in context.
- Plain-language summary written by qwen3.6:35b-a3b on October 13, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.